HRMY
Harmony Biosciences Holdings
40.30$
+1.7%
vs. previous close
Closing price · As of: Oct 9, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| – | – | – | 26.3% | 17.5% | 17.0% | 17.3% | 17.6% | 17.4% | 17.2% | 18.1% | 19.5% | 17.2% | 17.7% | 19.6% | 21.0% | 17.4% | 18.6% | 20.2% | 25.6% | 17.8% | 18.6% | 23.0% | 27.0% | 17.3% | 19.0% | 24.9% | 28.1% | 20.7% | 24.2% | 24.6% | |
| – | – | – | 73.7% | 82.5% | 83.0% | 82.7% | 82.4% | 82.6% | 82.8% | 81.9% | 80.5% | 82.8% | 82.3% | 80.4% | 79.0% | 82.6% | 81.4% | 79.8% | 74.4% | 82.2% | 81.4% | 77.0% | 73.0% | 82.7% | 81.0% | 75.1% | 71.9% | 79.3% | 75.8% | 75.4% | |
| – | – | – | 121.4% | 17.3% | 11.0% | 9.3% | 13.5% | 7.8% | 8.8% | 14.5% | 8.2% | 8.9% | 11.8% | 34.6% | 7.9% | 11.2% | 11.2% | 10.9% | 18.0% | 14.4% | 36.8% | 13.6% | 17.2% | 18.7% | 25.0% | 23.0% | 20.5% | 32.2% | 17.8% | 23.0% | |
| – | – | – | 233.4% | 46.8% | 20.1% | 23.0% | 23.9% | 24.4% | 19.4% | 20.9% | 20.0% | 21.0% | 20.7% | 18.2% | 17.6% | 18.5% | 17.0% | 14.1% | 16.5% | 16.6% | 15.8% | 15.4% | 14.3% | 16.9% | 16.9% | 12.4% | 23.6% | 15.1% | 10.7% | 15.4% | |
| – | – | – | 635.7% | 130.9% | 63.8% | 59.9% | 68.6% | 58.2% | 51.2% | 55.8% | 49.1% | 50.5% | 51.4% | 70.3% | 41.9% | 48.6% | 46.4% | 39.6% | 50.5% | 48.6% | 69.0% | 43.8% | 45.3% | 52.2% | 56.9% | 47.7% | 56.1% | 62.0% | 41.6% | 51.4% | |
| – | – | – | -562.0% | -48.4% | 19.2% | 22.8% | 13.8% | 24.4% | 31.6% | 26.1% | 31.4% | 32.3% | 30.9% | 10.2% | 37.1% | 33.9% | 34.9% | 40.3% | 23.9% | 33.7% | 12.4% | 33.2% | 27.7% | 30.4% | 24.0% | 27.3% | 15.8% | 17.3% | 34.2% | 24.0% | |
| – | – | – | 45.8% | 32.1% | 18.3% | 15.2% | 14.2% | 11.9% | 9.8% | 6.8% | 4.7% | 5.0% | 3.9% | 4.2% | 2.8% | 4.8% | 4.6% | 4.4% | 2.8% | 2.9% | 2.5% | 2.3% | 2.1% | 2.1% | 1.8% | 1.5% | 1.5% | 1.5% | 1.2% | 1.4% | |
| – | – | – | -607.8% | -194.7% | -0.1% | 4.2% | -0.4% | 12.4% | 21.8% | -13.0% | 26.8% | 27.4% | 27.3% | 6.8% | 34.4% | 31.7% | 32.9% | 32.3% | 23.6% | 33.5% | 12.6% | 33.4% | 27.9% | 31.0% | 24.8% | 28.2% | 16.7% | 18.4% | 35.7% | 25.1% | |
| – | – | – | – | 146.2% | 18.3% | 11.9% | -7.8% | 11.9% | 2.7% | -1.1% | 1.9% | 2.2% | 5.3% | -68.2% | -3.4% | 7.0% | 7.3% | 8.3% | 7.8% | 8.7% | 5.8% | 8.6% | 3.3% | 6.3% | 4.9% | 6.9% | 7.5% | 3.3% | 6.8% | 6.2% | |
| – | – | – | -607.8% | -194.7% | -0.1% | 4.2% | -0.4% | 12.4% | 19.1% | -11.9% | 24.9% | 25.2% | 22.0% | 75.0% | 37.8% | 24.8% | 25.6% | 24.0% | 15.8% | 24.8% | 6.7% | 24.8% | 24.6% | 24.7% | 19.8% | 21.2% | 9.2% | 15.1% | 28.9% | 18.9% | |
| – | – | – | -529.6% | -38.9% | 24.5% | 27.1% | 21.6% | 32.2% | 38.0% | -0.5% | 8.0% | 38.4% | 36.6% | 15.4% | 41.9% | 41.6% | 42.0% | 40.5% | 36.4% | 40.4% | 18.6% | 39.0% | 33.0% | 36.3% | 29.6% | 30.7% | 21.2% | 22.7% | 39.2% | 28.8% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 9, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.